Tech Company Financing Transactions

TearSolutions Funding Round

TearSolutions secured a $1.1 million funding round on 2/27/2017. Backers included private investors.

Transaction Overview

Company Name
Announced On
2/27/2017
Transaction Type
Venture Equity
Amount
$1,080,346
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 12 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
315 Old Ivy Way 301
Charlottesville, VA 22903
USA
Email Address
Not Recorded
Overview
Human tears supply and protect the surface of the eye. Several tear proteins are deficient in dry eye, the most common eye disease. One is essential and when reintroduced to dry eye tears, health is restored. Lacripep is a first-in-class topical synthetic peptide treatment for dry eye that addresses cause.
Profile
TearSolutions LinkedIn Company Profile
Social Media
TearSolutions Company Twitter Account
Company News
TearSolutions News
Facebook
TearSolutions on Facebook
YouTube
TearSolutions on YouTube

Management Team

Title
Name
Email & Social
Chairman
Mark Logan
  Mark Logan LinkedIn Profile  Mark Logan Twitter Account  Mark Logan News  Mark Logan on Facebook
Chief Executive Officer
Thomas Gadek
  Thomas Gadek LinkedIn Profile  Thomas Gadek Twitter Account  Thomas Gadek News  Thomas Gadek on Facebook
Chief Financial Officer
Colin Rolph
  Colin Rolph LinkedIn Profile  Colin Rolph Twitter Account  Colin Rolph News  Colin Rolph on Facebook
Chief Medical Officer
Marc Odrich
  Marc Odrich LinkedIn Profile  Marc Odrich Twitter Account  Marc Odrich News  Marc Odrich on Facebook
Chief Scientific Officer
Gordon Laurie
  Gordon Laurie LinkedIn Profile  Gordon Laurie Twitter Account  Gordon Laurie News  Gordon Laurie on Facebook
VP - Regulatory Affairs
Michelle Carpenter
  Michelle Carpenter LinkedIn Profile  Michelle Carpenter Twitter Account  Michelle Carpenter News  Michelle Carpenter on Facebook


 

 

Browse more venture capital transactions:

Prev: 2/24/2017: Mercatus venture capital transaction
Next: 2/27/2017: Outlier.ai venture capital transaction

 

Share this article

 


News on VC Transactions

We report on funding rounds that are announced publicly. VC investment data records on this site are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary